DRJ announces sales increased 31 percent for FY 2008

ENCINITAS, Calif. DRJ Group Inc., the makers of Stopain topical analgesics, on Thursday announced that sales increased 31 percent overall during its fiscal year 2008 ending June 30.

The most dramatic growth was in the grocery and health food category, which grew by 69 percent.

“We made some great enhancements to Stopain during the past 12 months,” stated Bob Miller, president and chief executive officer of DRJ. “This included adding our new, patented cream formula; improving on-shelf visibility with easy-to-read packaging; and widening the availability of our Stopain product family through increased distribution at some of the country’s major retailers and on our brand’s web site.”

Earlier this year, Meijer supercenters throughout Michigan, Indiana, Illinois, Ohio and Kentucky began carrying Stopain products. In May, the sale of Stopain Spray and Roll-on began in Wal-Mart locations throughout the United States, the company stated.

The Emerson Group, a national sales organization that represents DRJ Group, reports that Stopain experienced one of the largest sales percentage increases of any of its clients during fiscal year 2008.

Stopain products include the company’s new patented cream formula, as well as spray and roll-on SKUs.

Stopain can be purchased nationally in over 25,000 independent pharmacies and national chain drug stores, including Walgreens, Wal-Mart, CVS and Rite-Aid.